Article(id=1322906919035347565, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322887411688919265, articleNumber=null, orderNo=null, doi=null, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=null, receivedDateStr=null, revisedDate=null, revisedDateStr=null, acceptedDate=1624464000000, acceptedDateStr=2021-06-24, onlineDate=1793335187919, onlineDateStr=2026-10-30, pubDate=1636905600000, pubDateStr=2021-11-15, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793335187919, onlineIssueDateStr=2026-10-30, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793335187919, creator=13701087609, updateTime=1793335187919, updator=13701087609, issue=Issue{id=1322887411688919265, tenantId=1146029695717560320, journalId=1235980733773295621, year='2021', volume='30', issue='21', pageStart='1921', pageEnd='2016', issueExtLink='null', onlineDate='null', pubDate='1636905600000', pubDateStr='2021-11-15', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793330537006, creator='13701087609', updateTime=1793337443794, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1322916380919608076, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322887411688919265, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1322916380919608077, tenantId=1146029695717560320, journalId=1235980733773295621, issueId=1322887411688919265, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1956, endPage=1960, ext={EN=ArticleExt(id=1322906919253451374, articleId=1322906919035347565, tenantId=1146029695717560320, journalId=1235980733773295621, language=EN, title=General considerations for viral safety control of recombinant therapeutic biotechnological products during the CTA phase, columnId=null, journalTitle=Chinese Journal of New Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=

The risk control of viral contamination has always been an important part of the safety control of recombinant biotechnology products. At present, China has not issued technical guidelines for viral safety control in the clinical trial application stage for recombinant therapeutic biotech products, while the sources of technical guidelines in the marketing stage are complicated, which to some extent brings troubles to researchers and delays the development process of new drugs. Therefore, in order to improve the R&D quality of related products and accelerate the application process, this article will discuss the basic technical requirements for viral safety control of recombinant therapeutic biotechnology products in the clinical trial application phase from three aspects: the technical requirements of the current technical guidelines, the technical requirements of the Chinese Pharmacopoeia, and the review practice.

, authors=Wen-bo SAI, Sheng-nan GUO, Kai-kun WEI, authorsList=Wen-bo SAI, Sheng-nan GUO, Kai-kun WEI, authorCompany=null, correspAuthors=Kai-kun WEI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1322906919568024175, articleId=1322906919035347565, tenantId=1146029695717560320, journalId=1235980733773295621, language=CN, title=重组治疗用生物技术产品临床试验申报阶段病毒安全控制的一般考量, columnId=1236331159400018080, journalTitle=中国新药杂志, columnName=新药注册与审评技术, runingTitle=null, highlight=null, articleAbstract=

病毒污染风险控制一直是重组生物技术产品安全性控制的重要组成部分。目前我国尚未针对重组治疗用生物技术产品出台临床试验申报阶段病毒安全控制技术指南,而上市阶段的技术指南来源较为繁复,在一定程度上给研究人员带来了困扰,延缓了新药的研发进程。因此,本文将从现行指导原则的技术要求、现行版《中华人民共和国药典》技术要求和审评实践3个方面,对重组治疗用生物技术产品在临床试验申报阶段病毒安全控制的基本技术要求进行讨论,以期能提高相关产品的研发质量,加速申报进程。

, authors=赛文博, 郭胜楠, 魏开坤, authorsList=赛文博, 郭胜楠, 魏开坤, authorCompany=null, correspAuthors=魏开坤, authorNote=

赛文博,男,助理研究员,研究方向:治疗用生物制品药学技术审评。联系电话:(010)85243042,E-mail:。

, correspAuthorsNote=
魏开坤,男,助理研究员,研究方向:治疗性生物制品药学技术审评。联系电话:(010)85242990,E-mail:。
, copyrightStatement=null, copyrightOwner=《中国新药杂志》有限公司, extLink=null, articleAbsUrl=null, sourceXml=unnoAAH6DEOXO2UJ+UvOAg==, magXml=AC5djfnqJRkKi1nnRYcVdw==, pdfUrl=null, pdf=PlRBdgh05LQupKvFgarOnQ==, pdfFileSize=892129, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=6mwfUQpU0QYW84VtYSTQYg==, mapNumber=null, fund=null)}, authors=[Author(id=1322906919937122932, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=saiwb@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322906920058757750, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, authorId=1322906919937122932, language=EN, stringName=Wen-bo SAI, firstName=Wen-bo, middleName=null, lastName=SAI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906920159421047, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, authorId=1322906919937122932, language=CN, stringName=赛文博, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio={"content":"

赛文博,男,助理研究员,研究方向:治疗用生物制品药学技术审评。联系电话:(010)85243042,E-mail:。

"}, bioImg=null, bioContent=

赛文博,男,助理研究员,研究方向:治疗用生物制品药学技术审评。联系电话:(010)85243042,E-mail:。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906919857431152, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, xref=null, ext=[AuthorCompanyExt(id=1322906919865819761, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, companyId=1322906919857431152, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China), AuthorCompanyExt(id=1322906919874208370, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, companyId=1322906919857431152, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1322906921807782521, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322906921904251515, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, authorId=1322906921807782521, language=EN, stringName=Sheng-nan GUO, firstName=Sheng-nan, middleName=null, lastName=GUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906921975554684, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, authorId=1322906921807782521, language=CN, stringName=郭胜楠, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906919857431152, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, xref=null, ext=[AuthorCompanyExt(id=1322906919865819761, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, companyId=1322906919857431152, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China), AuthorCompanyExt(id=1322906919874208370, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, companyId=1322906919857431152, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1322906922042663550, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=weikk@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1322906922139132544, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, authorId=1322906922042663550, language=EN, stringName=Kai-kun WEI, firstName=Kai-kun, middleName=null, lastName=WEI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906922206241409, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, authorId=1322906922042663550, language=CN, stringName=魏开坤, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906919857431152, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, xref=null, ext=[AuthorCompanyExt(id=1322906919865819761, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, companyId=1322906919857431152, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China), AuthorCompanyExt(id=1322906919874208370, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, companyId=1322906919857431152, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])])], keywords=[Keyword(id=1322906922323681922, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, language=EN, orderNo=1, keyword=recombinant therapeutic biotechnological products), Keyword(id=1322906922378207875, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, language=EN, orderNo=2, keyword=viral safety control), Keyword(id=1322906922457899652, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, language=EN, orderNo=3, keyword=virus removal/inactivation), Keyword(id=1322906922541785733, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, language=CN, orderNo=1, keyword=重组治疗性生物技术产品), Keyword(id=1322906922625671814, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, language=CN, orderNo=2, keyword=病毒安全控制), Keyword(id=1322906922709557895, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, language=CN, orderNo=3, keyword=病毒去除/灭活)], refs=[Reference(id=1322906922826998408, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=原国家食品药品监督管理总局. 生物组织提取制品和真核细胞表达制品的病毒安全性评价技术审评一般原则[EB/OL]. [2008]. http://www.cde.org.cn/zdyz.do?method=largePage&id=71fc578fd703429e., articleTitle=null, refAbstract=null), Reference(id=1322906922894107273, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=ICH Q5A. Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin[EB/OL]. [1998]. https://www.ich.org/products/guidelines/quality/article/qualityguidelines.html., articleTitle=null, refAbstract=null), Reference(id=1322906922969604746, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=EMA. Virus safety evaluation of biotechnological investigational medicinal products[EB/OL]. [2008]. https://www.ema.europa.eu/en/virus-safety-evaluation-biotechnological-investigational-medicinal-products., articleTitle=null, refAbstract=null), Reference(id=1322906923066073739, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药典委员会. 中华人民共和国药典[S]. 2020版. 北京: 中国医药科技出版社, 2020., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1322906919857431152, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, xref=null, ext=[AuthorCompanyExt(id=1322906919865819761, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, companyId=1322906919857431152, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China), AuthorCompanyExt(id=1322906919874208370, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, companyId=1322906919857431152, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])], figs=null, attaches=null, journal=Journal(id=1235980159023624194, delFlag=0, nameCn=中国新药杂志, nameEn=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, issn=1003-3734, eissn=null, cn=11-2850/R, coden=ZXZHA6, periodic=3, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of New Drugs, journalRemark=null, publicationField=null, createdTime=1772610233314, updatedTime=1788948968376, createdBy=18614031015, updatedBy=13041195026, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=ohPEEN//Vz1tDT3ZBNTp4Q==, picEn=f9WK9bvTM4guTmS/iGhOMg==, jcr=null, cjcr=null, exts=[JournalExt(id=1304509780974924039, language=CN, name=中国新药杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968404, updatedTime=1788948968404, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1304509781025255688, language=EN, name=Chinese Journal of New Drugs, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1788948968416, updatedTime=1788948968416, createdBy=13041195026, updatedBy=13041195026, submissionGuidelinesUrl=, submissionAuthorUrl=http://draft.newdrug.cn/journalx_zgxy/authorLogOn.action, submissionEditorUrl=http://draft.newdrug.cn/journalx_zgxy/editorLogOn.action, submissionReviewUrl=http://draft.newdrug.cn/journalx_zgxy/expertLogOn.action, submissionCeEditorUrl=, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1235980733773295621, websiteList=[Website(id=1235982099191222761, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/CN, language=CN, createTime=1772610695884, createBy=18614031015, updateTime=1772610860397, updateBy=18614031015, name=中国新药杂志-中文, tplId=1146099689490845704, title=中国新药杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983918629966444, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=articleTextType, value=kx, createTime=1772611129672, updateTime=1772611129672, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918604800617, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=banner, value=null, createTime=1772611129666, updateTime=1772611129666, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918655132271, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=grayFlag, value=0, createTime=1772611129678, updateTime=1772611129678, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918596412008, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611129664, updateTime=1772611129664, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918667715185, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=minRunFlag, value=0, createTime=1772611129681, updateTime=1772611129681, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918617383531, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/file/pic, createTime=1772611129669, updateTime=1772611129669, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918659326576, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=silenceFlag, value=0, createTime=1772611129679, updateTime=1772611129679, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918613189226, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1772611129668, updateTime=1772611129668, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918634160749, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeColor, value=null, createTime=1772611129673, updateTime=1772611129673, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983918646743662, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099191222761, code=themeStyle, value=null, createTime=1772611129676, updateTime=1772611129676, creator=18614031015, updator=18614031015)]), Website(id=1235982099270914542, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1235980733773295621, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgxyzz/EN, language=EN, createTime=1772610695903, createBy=18614031015, updateTime=1772610875891, updateBy=18614031015, name=中国新药杂志-英文, tplId=1146101810881728533, title=Chinese Journal of New Drugs, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1235983955829248630, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=articleTextType, value=kx, createTime=1772611138541, updateTime=1772611138541, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955804082803, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=banner, value=null, createTime=1772611138535, updateTime=1772611138535, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955854414457, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=grayFlag, value=0, createTime=1772611138547, updateTime=1772611138547, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955795694194, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=logo, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic?fileId=W567vm71kFC7UhK9TSU6xw==, createTime=1772611138533, updateTime=1772611138533, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955866997371, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=minRunFlag, value=0, createTime=1772611138550, updateTime=1772611138550, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955820860021, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/file/pic, createTime=1772611138539, updateTime=1772611138539, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955862803066, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=silenceFlag, value=0, createTime=1772611138549, updateTime=1772611138549, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955812471412, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1772611138537, updateTime=1772611138537, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955837637239, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeColor, value=null, createTime=1772611138543, updateTime=1772611138543, creator=18614031015, updator=18614031015), WebsiteProps(id=1235983955846025848, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1235982099270914542, code=themeStyle, value=null, createTime=1772611138545, updateTime=1772611138545, creator=18614031015, updator=18614031015)])], journalTitle=中国新药杂志, weixinUrl=null, journalUrl=http://www.newdrug.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of New Drugs, journalPhotoCn=ohPEEN//Vz1tDT3ZBNTp4Q==, journalPhotoEn=f9WK9bvTM4guTmS/iGhOMg==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/Y2021/V30/I21/1956, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/Y2021/V30/I21/1956, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgxyzz/CN/PDF/Y2021/V30/I21/1956, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgxyzz/EN/PDF/Y2021/V30/I21/1956, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1636905600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
重组治疗用生物技术产品临床试验申报阶段病毒安全控制的一般考量
收藏切换
PDF下载
赛文博 , 郭胜楠 , 魏开坤
中国新药杂志 | 新药注册与审评技术 2021,30(21): 1956-1960
收起
收藏切换
中国新药杂志 |新药注册与审评技术 2021 , 30 (21) : 1956 -1960
重组治疗用生物技术产品临床试验申报阶段病毒安全控制的一般考量
全屏
[Author(id=1322906919937122932, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=saiwb@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322906920058757750, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, authorId=1322906919937122932, language=EN, stringName=Wen-bo SAI, firstName=Wen-bo, middleName=null, lastName=SAI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906920159421047, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, authorId=1322906919937122932, language=CN, stringName=赛文博, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio={"content":"

赛文博,男,助理研究员,研究方向:治疗用生物制品药学技术审评。联系电话:(010)85243042,E-mail:。

"}, bioImg=null, bioContent=

赛文博,男,助理研究员,研究方向:治疗用生物制品药学技术审评。联系电话:(010)85243042,E-mail:。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906919857431152, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, xref=null, ext=[AuthorCompanyExt(id=1322906919865819761, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, companyId=1322906919857431152, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China), AuthorCompanyExt(id=1322906919874208370, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, companyId=1322906919857431152, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1322906921807782521, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1322906921904251515, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, authorId=1322906921807782521, language=EN, stringName=Sheng-nan GUO, firstName=Sheng-nan, middleName=null, lastName=GUO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906921975554684, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, authorId=1322906921807782521, language=CN, stringName=郭胜楠, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906919857431152, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, xref=null, ext=[AuthorCompanyExt(id=1322906919865819761, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, companyId=1322906919857431152, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China), AuthorCompanyExt(id=1322906919874208370, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, companyId=1322906919857431152, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])]), Author(id=1322906922042663550, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=weikk@cde.org.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1322906922139132544, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, authorId=1322906922042663550, language=EN, stringName=Kai-kun WEI, firstName=Kai-kun, middleName=null, lastName=WEI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1322906922206241409, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, authorId=1322906922042663550, language=CN, stringName=魏开坤, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=国家药品监督管理局药品审评中心,北京 100022, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1322906919857431152, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, xref=null, ext=[AuthorCompanyExt(id=1322906919865819761, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, companyId=1322906919857431152, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China), AuthorCompanyExt(id=1322906919874208370, tenantId=1146029695717560320, journalId=1235980733773295621, articleId=1322906919035347565, companyId=1322906919857431152, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=国家药品监督管理局药品审评中心,北京 100022)])])]
赛文博 , 郭胜楠, 魏开坤
作者信息
  • 国家药品监督管理局药品审评中心,北京 100022
通讯作者:
魏开坤,男,助理研究员,研究方向:治疗性生物制品药学技术审评。联系电话:(010)85242990,E-mail:。
作者简介:

赛文博,男,助理研究员,研究方向:治疗用生物制品药学技术审评。联系电话:(010)85243042,E-mail:。

General considerations for viral safety control of recombinant therapeutic biotechnological products during the CTA phase
Wen-bo SAI , Sheng-nan GUO, Kai-kun WEI
Affiliations
  • Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China
出版时间: 2021-11-15
文章导航
收藏切换

病毒污染风险控制一直是重组生物技术产品安全性控制的重要组成部分。目前我国尚未针对重组治疗用生物技术产品出台临床试验申报阶段病毒安全控制技术指南,而上市阶段的技术指南来源较为繁复,在一定程度上给研究人员带来了困扰,延缓了新药的研发进程。因此,本文将从现行指导原则的技术要求、现行版《中华人民共和国药典》技术要求和审评实践3个方面,对重组治疗用生物技术产品在临床试验申报阶段病毒安全控制的基本技术要求进行讨论,以期能提高相关产品的研发质量,加速申报进程。

重组治疗性生物技术产品  /  病毒安全控制  /  病毒去除/灭活

The risk control of viral contamination has always been an important part of the safety control of recombinant biotechnology products. At present, China has not issued technical guidelines for viral safety control in the clinical trial application stage for recombinant therapeutic biotech products, while the sources of technical guidelines in the marketing stage are complicated, which to some extent brings troubles to researchers and delays the development process of new drugs. Therefore, in order to improve the R&D quality of related products and accelerate the application process, this article will discuss the basic technical requirements for viral safety control of recombinant therapeutic biotechnology products in the clinical trial application phase from three aspects: the technical requirements of the current technical guidelines, the technical requirements of the Chinese Pharmacopoeia, and the review practice.

recombinant therapeutic biotechnological products  /  viral safety control  /  virus removal/inactivation
赛文博, 郭胜楠, 魏开坤. 重组治疗用生物技术产品临床试验申报阶段病毒安全控制的一般考量. 中国新药杂志, 2021 , 30 (21) : 1956 -1960 .
Wen-bo SAI, Sheng-nan GUO, Kai-kun WEI. General considerations for viral safety control of recombinant therapeutic biotechnological products during the CTA phase[J]. Chinese Journal of New Drugs, 2021 , 30 (21) : 1956 -1960 .

参考文献 引证文献
排序方式:
[1]
原国家食品药品监督管理总局. 生物组织提取制品和真核细胞表达制品的病毒安全性评价技术审评一般原则[EB/OL]. [2008]. http://www.cde.org.cn/zdyz.do?method=largePage&id=71fc578fd703429e.
[2]
ICH Q5A. Viral safety evaluation of biotechnology products derived from cell lines of human or animal origin[EB/OL]. [1998]. https://www.ich.org/products/guidelines/quality/article/qualityguidelines.html.
[3]
EMA. Virus safety evaluation of biotechnological investigational medicinal products[EB/OL]. [2008]. https://www.ema.europa.eu/en/virus-safety-evaluation-biotechnological-investigational-medicinal-products.
[4]
国家药典委员会. 中华人民共和国药典[S]. 2020版. 北京: 中国医药科技出版社, 2020.
2021年第30卷第21期
PDF下载
7
1
引用本文
BibTeX
文章信息
  • 首发时间:2026-10-30
  • 出版时间:2021-11-15
补充材料
相关文章
文章信息
作者
出版历史
  • 录用日期:2021-06-24
基金
作者信息
    国家药品监督管理局药品审评中心,北京 100022

通讯作者:

魏开坤,男,助理研究员,研究方向:治疗性生物制品药学技术审评。联系电话:(010)85242990,E-mail:。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgxyzz/CN/1322906919035347565
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏